Skip to main content
Journal of Psychiatry & Neuroscience: JPN logoLink to Journal of Psychiatry & Neuroscience: JPN
letter
. 2000 May;25(3):281.

Chlorpromazine-induced cutaneous pigmentation--effect of replacement with clozapine.

S Lal, S Lal
PMCID: PMC1407720  PMID: 10863889

Full text

PDF

Page 281

281

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ban T. A., Guy W., Wilson W. H. Neuroleptic-induced skin pigmentation in chronic hospitalized schizophrenic patients. Can J Psychiatry. 1985 Oct;30(6):406–408. doi: 10.1177/070674378503000605. [DOI] [PubMed] [Google Scholar]
  2. Ewing D. G., Einarson T. R. Loxapine as an alternative to phenothiazines in a case of oculocutaneous skin pigmentation. Am J Psychiatry. 1981 Dec;138(12):1631–1632. doi: 10.1176/ajp.138.12.1631. [DOI] [PubMed] [Google Scholar]
  3. GREINER A. C., BERRY K. SKIN PIGMENTATION AND CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE THERAPY. Can Med Assoc J. 1964 Mar 14;90:663–665. [PMC free article] [PubMed] [Google Scholar]
  4. Lal S., Bloom D., Silver B., Desjardins B., Krishnan B., Thavundayil J., Thompson T. Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes. J Psychiatry Neurosci. 1993 Jul;18(4):173–177. [PMC free article] [PubMed] [Google Scholar]
  5. O'Croinin F., Zibin T. Re: Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes. J Psychiatry Neurosci. 1994 May;19(3):226–226. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Psychiatry and Neuroscience are provided here courtesy of Canadian Science Publishing

RESOURCES